Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check3 days agoChange DetectedThe Study Protocol revision has been updated from v3.5.2 to v3.5.3, replacing the prior version with a newer protocol document in the Study Protocol section.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed on the page. This appears to be a minor internal update with no impact on study content or user interactions.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded Revision: v3.4.2 to the page and removed older entries including the funding status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check89 days agoChange DetectedAdded a site-wide notice about government funding and current NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.